Pharmacology

You are here

NIH Consensus Panel

Dr. Charles E. Inturrisi was a member of an NIH Consensus Panel that met in Bethesda, MD, from February 24 to 27, 2008, to review the use of hydroxyurea for the treatment of sickle cell disease (SCD). The panel issued a statement that made a number of recommendations including the increased use of hydroxyurea for the treatment of the nearly 100,000 Americans affected by this disease (http://consensus.nih.gov/).

Date

Apr 06, 2008

Time

1:15pm

Weill Cornell Medicine Pharmacology 1300 York Avenue,
Room E-409
New York, NY 10021 Phone: (212) 746-6250 Fax: (212) 746-8835